Table 1.
GI manifestations and distress in ASD patients and animal models.
Gene | GI manifestation | GI distress | Study type | ENS phenotype | Reference |
---|---|---|---|---|---|
CHD8/chd8 | Slow GI transit | Constipation and diarrhea | ASD patients, Danio rerio | 50% reduction of enteric neurons in hindgut of chd8 morphants | Bernier et al. [7] |
NOS1 | Achalasia | Eating and drinking problems | ASD patients | Not analyzed | Shteyer et al. [8] |
Nos1 | Hypertensive and poorly relaxing lower esophageal sphincter | Eating and drinking problems | Nos −/− mice | Interstitial cells of Cajal impaired | Sivarao et al. [9] |
Tcf4 | Slow GI transit | Constipation | Tcf4 +/− mice Pitt–Hopkins mouse model | Not analyzed | Grubisic et al. [10] |
Slc6a4 (Sert) | Slow GI transit, villus height and crypt depth decreased in mucosal structure | Constipation | Sert Ala56 mice | Reduced number of neurons in plexus of small and large intestines and TH, CGRP, or GABA positive neurons | Margolis et al. [12] |
Foxp1 | Achalasia, impaired relaxation of the lower esophageal sphincter, slow GI transit, reduced thickness of tunica muscularis in esophagus and colon | Eating and drinking problems, constipation | Foxp1 +/− mice | Not analyzed | Fröhlich et al. [11] |
Nlgn3 | Increased GI transit GABA-mediated alterations of colon motility | Diarrhea | NL3R451C mice | Hyperplasia in small intestine, dysregulation of GABAergic neurons | Hosie et al. [13] |
NLGN3 | Various GI complaints | Diarrhea poor bowel control, esophagitis, esophageal regurgitation, abdominal pain | ASD patients with NLGN3 p.R451C variant | Not analyzed | Hosie et al. [13] |
Nlgn3 | Faster colonic migrating motor complexes, increased colonic diameter | Not described, likely diarrhea | Nlgn3 −/− mice | No changes in ENS, inhibitory interneurons | Leembruggen et al. [14] |
shank3a/shank3b | Slow GI transit, reduced peristalsis and motility, serotonin-positive enteroendocrine cells reduced | Constipation and/or diarrhea, reflux, cyclical vomiting | Danio rerio Phelan-McDermid syndrome (ASD) shank3abΔC+/− | No changes | James et al. [15] |